RJ

Reena Jindal

Active Director Director DIN 07864865
DIN 07864865 First appointment Jun 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2017
Shareholding value •••• Premium profile

About Reena Jindal

Data last updated:

Reena Jindal is a Director at Riya Life Sciences Private Limited (since 2017). The company operates in Pharma. Riya Life Sciences Private Limited reported revenue of ₹5.70 Cr (FY 2024).

DIN 07864865
Primary Designation Director
Industry Pharma
First Appointment 30 Jun 2017
Oldest Company Age 9 yrs
Largest company Riya Life Sciences Private Limited · ₹5.70 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Riya Life Sciences Private Limited U74999DL2017PTC319987
Director30 Jun 20172017₹5.70 Cr (FY 2024)Active

Board colleagues of Reena Jindal

NameDINCompanyDesignation
Puneet Jindal07864864Riya Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Riya Life Sciences Private Limited
Premium access

Shareholding and investment profile for Reena Jindal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Jindal

Reena Jindal currently holds 1 directorship: Riya Life Sciences Private Limited (Director, since 30 Jun 2017, revenue ₹5.70 Cr (FY 2024)).

Reena Jindal was first appointed on 30 Jun 2017 as Director at Riya Life Sciences Private Limited.

The current boards of Reena Jindal's companies include Puneet Jindal (Riya Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available